All News Calithera Biosciences, Inc.

Equities

CALA

US13089P5070

Market Closed - OTC Markets Other stock markets 15:36:06 28/06/2024 BST			5-day change	1st Jan Change
0.01 ^USD	0.00%		-20.00%	-66.67%

2023	Calithera Biosciences, Inc. Launches the Cala kIQ System, Offering Meaningful Tremor Relief for Patients with Essential Tremor and Now Parkinson’s Disease	CI
2023	North American Morning Briefing : Stock Futures -2-	DJ

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Calithera Biosciences, Inc. Launches the Cala kIQ System, Offering Meaningful Tremor Relief for Patients with Essential Tremor and Now Parkinson’s Disease	14/06/23	CI
North American Morning Briefing : Stock Futures -2-	23/05/23	DJ
North American Morning Briefing : Retail Sales, -2-	16/05/23	DJ
Calithera Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23	CI
Calithera Biosciences, Inc. Auditor Raises 'Going Concern' Doubt	30/03/23	CI
Calithera Biosciences, Inc.(NasdaqGS:CALA) dropped from S&P TMI Index	06/02/23	CI
Calithera Biosciences, Inc.(NasdaqGS:CALA) dropped from NASDAQ Composite Index	01/02/23	CI
Top Premarket Decliners	25/01/23	MT
Calithera Biosciences Shares Set to be Suspended From Nasdaq on Feb. 2; Stock Declines Premarket	25/01/23	MT
CALITHERA BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	25/01/23	AQ
Top Midday Decliners	09/01/23	MT
Calithera Biosciences to Proceed With Liquidation and Dissolution of Company	09/01/23	MT
CALITHERA BIOSCIENCES, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	09/01/23	AQ
Calithera Biosciences, Inc. Announces Departure of Susan M. Molineaux as Chief Executive Officer	09/01/23	CI
Calithera Biosciences, Inc. Announces Departure of Stephanie Wong as Chief Financial Officer	09/01/23	CI
Calithera Biosciences, Inc. Announces Executive Departures	09/01/23	CI
Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution	09/01/23	AQ
Antengene Signs Assignment Deal with Calithera to Acquire Rights on Cancer Tumor Drug; Shares Climb 10%	05/01/23	MT
Antengene Corporation Limited Enters into Assignment Agreement with Calithera Biosciences, Inc. to Acquire All Outstanding Rights of ATG-037	04/01/23	CI
North American Morning Briefing : Stock Futures -2-	16/11/22	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Calithera Biosciences, Inc.

Equities

CALA

US13089P5070

All News

Filters